schliessen

Filtern

 

Bibliotheken

Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study

Summary Background Ovarian cancer is commonly fatal and incidence has persistently risen in Taiwan over the past 20 years. Prevention strategies, however, are limited. Pelvic inflammatory disease (PID) has been suggested to increase the risk of developing ovarian cancer, but the results of studies h... Full description

Journal Title: The lancet oncology 2011, Vol.12 (9), p.900-904
Main Author: Lin, Hui-Wen, PhD
Other Authors: Tu, Ying-Yueh, MD , Lin, Shiyng Yu, MD , Su, Wei-Ju, MA , Lin, Wei Li, BA , Lin, Wei Zer, BA , Wu, Shen-Chi, MD , Lai, Yuen-Liang, Dr
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: England: Elsevier Ltd
ID: ISSN: 1470-2045
Link: https://www.ncbi.nlm.nih.gov/pubmed/21835693
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_886603031
title: Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study
format: Article
creator:
  • Lin, Hui-Wen, PhD
  • Tu, Ying-Yueh, MD
  • Lin, Shiyng Yu, MD
  • Su, Wei-Ju, MA
  • Lin, Wei Li, BA
  • Lin, Wei Zer, BA
  • Wu, Shen-Chi, MD
  • Lai, Yuen-Liang, Dr
subjects:
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Cancer
  • Case-Control Studies
  • Comorbidity
  • Databases as Topic
  • Development and progression
  • Family medicine
  • Female
  • Follow-Up Studies
  • Hematology, Oncology and Palliative Medicine
  • Humans
  • Kaplan-Meier Estimate
  • Medical colleges
  • Middle Aged
  • National Health Programs - statistics & numerical data
  • Oncology, Experimental
  • Ovarian cancer
  • Ovarian Neoplasms - epidemiology
  • Pelvic inflammatory disease
  • Pelvic Inflammatory Disease - epidemiology
  • Proportional Hazards Models
  • Research
  • Risk Assessment
  • Risk Factors
  • Socioeconomic Factors
  • Taiwan - epidemiology
  • Time Factors
  • Women
  • Young Adult
ispartof: The lancet oncology, 2011, Vol.12 (9), p.900-904
description: Summary Background Ovarian cancer is commonly fatal and incidence has persistently risen in Taiwan over the past 20 years. Prevention strategies, however, are limited. Pelvic inflammatory disease (PID) has been suggested to increase the risk of developing ovarian cancer, but the results of studies have been inconsistent. Therefore, we investigated whether PID increases the risk of developing ovarian cancer in a large, nationwide cohort. Methods From the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan, we obtained data for women aged 13–65 years for whom a diagnosis of PID, confirmed by multiple episodes, had been recorded between Jan 1, 2004, and Dec 31, 2005. We also obtained data for two controls per patient, matched for age and the year of first entry into the LHID2005. All patients were followed up from the date of entry in the LHID2005 until they developed ovarian cancer or to the end of 2006, whichever was earlier. We used Cox's regression models to assess the risk of developing ovarian cancer, with adjustment for age, comorbid disorders, and socioeconomic characteristics. Findings We identified 67 936 women with PID and 135 872 controls. Among these 90 had developed ovarian cancer during the 3-year follow-up period (42 patients with PID and 48 controls, incidence 2·78 and 1·44 per 10 000 person-years, respectively). The adjusted hazard ratio for ovarian cancer in patients with PID was 1·92 (95% CI 1·27–2·92) compared with controls, which rose to 2·46 (1·48–4·09) in women who had had at least five episodes of PID. The adjusted hazard ratio was slightly higher for women aged 35 years or younger with PID than in older women with PID (2·23, 1·02–4·79 vs 1·82, 1·10–3·04). Interpretation We found an association between PID and ovarian cancer. PID might, therefore, be a useful marker for ovarian cancer, and early treatment could help to improve prognosis. Whether pelvic inflammation itself accelerates the growth of ovarian cancers or affects cancer-cell differentiation in ways that adversely alter prognosis needs to be investigated. Funding None.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 1470-2045
fulltext: fulltext
issn:
  • 1470-2045
  • 1474-5488
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.626216
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_886603031
sourceformatXML
sourcesystemPC
galeidA265426822
sourcerecordidA265426822
originalsourceidFETCH-LOGICAL-c476t-ec70fd11242fe6bb29006ebf0ad76e2d5cef997396e67cd38bbcfbc310f3d8883
addsrcrecordideNqFkc2L1TAUxYsozjj6JyjBjbromJu0aTuCMgx-wYDgx8ZNSJMbzUza1KR98v57817HWbzNEGjC4Zwft_cUxVOgp0BBvP4GVUNLRqv6JcCrJkt1Ke4Vx1muyrpq2_v792o5Kh6ldEUpNEDrh8URg5bXouPHxc-vLl2TYEnYqOjUSLQaNUbiRvI3DJi_bv5NJvQbp7NovRoGNYe4JcYlVAnPiCJTmBavZhfGss-SIWlezPZx8cAqn_DJzX1S_Pjw_vvFp_Lyy8fPF-eXpa4aMZeoG2oNAKuYRdH3rKNUYG-pMo1AZmqNtusa3gkUjTa87Xtte82BWm7atuUnxYuVO8XwZ8E0y8Eljd6rEcOSZNsKQTnlkJ3PD5xXYYljHi6bGqiho3U2na6mX8qjzL8c5qh0PgYHp8OI1mX9nIm6YqJlLAfqNaBjSCmilVN0g4pbCVTuupL7ruSuCAkg911JkXPPbqZZ-gHNbep_Odnw5gCs3bxfc57I-Tvx79Y05t1vHEaZtMNcrnER9SxNcHcS3h4QtHej08pf4xbT7e5AJibpCtkxAPYEwf8BuN_K2Q
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid887151905
display
typearticle
titleRisk of ovarian cancer in women with pelvic inflammatory disease: a population-based study
sourceAlma/SFX Local Collection
creatorLin, Hui-Wen, PhD ; Tu, Ying-Yueh, MD ; Lin, Shiyng Yu, MD ; Su, Wei-Ju, MA ; Lin, Wei Li, BA ; Lin, Wei Zer, BA ; Wu, Shen-Chi, MD ; Lai, Yuen-Liang, Dr
creatorcontribLin, Hui-Wen, PhD ; Tu, Ying-Yueh, MD ; Lin, Shiyng Yu, MD ; Su, Wei-Ju, MA ; Lin, Wei Li, BA ; Lin, Wei Zer, BA ; Wu, Shen-Chi, MD ; Lai, Yuen-Liang, Dr
descriptionSummary Background Ovarian cancer is commonly fatal and incidence has persistently risen in Taiwan over the past 20 years. Prevention strategies, however, are limited. Pelvic inflammatory disease (PID) has been suggested to increase the risk of developing ovarian cancer, but the results of studies have been inconsistent. Therefore, we investigated whether PID increases the risk of developing ovarian cancer in a large, nationwide cohort. Methods From the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan, we obtained data for women aged 13–65 years for whom a diagnosis of PID, confirmed by multiple episodes, had been recorded between Jan 1, 2004, and Dec 31, 2005. We also obtained data for two controls per patient, matched for age and the year of first entry into the LHID2005. All patients were followed up from the date of entry in the LHID2005 until they developed ovarian cancer or to the end of 2006, whichever was earlier. We used Cox's regression models to assess the risk of developing ovarian cancer, with adjustment for age, comorbid disorders, and socioeconomic characteristics. Findings We identified 67 936 women with PID and 135 872 controls. Among these 90 had developed ovarian cancer during the 3-year follow-up period (42 patients with PID and 48 controls, incidence 2·78 and 1·44 per 10 000 person-years, respectively). The adjusted hazard ratio for ovarian cancer in patients with PID was 1·92 (95% CI 1·27–2·92) compared with controls, which rose to 2·46 (1·48–4·09) in women who had had at least five episodes of PID. The adjusted hazard ratio was slightly higher for women aged 35 years or younger with PID than in older women with PID (2·23, 1·02–4·79 vs 1·82, 1·10–3·04). Interpretation We found an association between PID and ovarian cancer. PID might, therefore, be a useful marker for ovarian cancer, and early treatment could help to improve prognosis. Whether pelvic inflammation itself accelerates the growth of ovarian cancers or affects cancer-cell differentiation in ways that adversely alter prognosis needs to be investigated. Funding None.
identifier
0ISSN: 1470-2045
1EISSN: 1474-5488
2DOI: 10.1016/S1470-2045(11)70165-6
3PMID: 21835693
4CODEN: LANCAO
languageeng
publisherEngland: Elsevier Ltd
subjectAdolescent ; Adult ; Age Factors ; Aged ; Cancer ; Case-Control Studies ; Comorbidity ; Databases as Topic ; Development and progression ; Family medicine ; Female ; Follow-Up Studies ; Hematology, Oncology and Palliative Medicine ; Humans ; Kaplan-Meier Estimate ; Medical colleges ; Middle Aged ; National Health Programs - statistics & numerical data ; Oncology, Experimental ; Ovarian cancer ; Ovarian Neoplasms - epidemiology ; Pelvic inflammatory disease ; Pelvic Inflammatory Disease - epidemiology ; Proportional Hazards Models ; Research ; Risk Assessment ; Risk Factors ; Socioeconomic Factors ; Taiwan - epidemiology ; Time Factors ; Women ; Young Adult
ispartofThe lancet oncology, 2011, Vol.12 (9), p.900-904
rights
0Elsevier Ltd
12011 Elsevier Ltd
2Copyright © 2011 Elsevier Ltd. All rights reserved.
3COPYRIGHT 2011 Elsevier B.V.
4Copyright Elsevier Limited Sep 2011
lds50peer_reviewed
citedbyFETCH-LOGICAL-c476t-ec70fd11242fe6bb29006ebf0ad76e2d5cef997396e67cd38bbcfbc310f3d8883
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21835693$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Lin, Hui-Wen, PhD
1Tu, Ying-Yueh, MD
2Lin, Shiyng Yu, MD
3Su, Wei-Ju, MA
4Lin, Wei Li, BA
5Lin, Wei Zer, BA
6Wu, Shen-Chi, MD
7Lai, Yuen-Liang, Dr
title
0Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study
1The lancet oncology
addtitleLancet Oncol
descriptionSummary Background Ovarian cancer is commonly fatal and incidence has persistently risen in Taiwan over the past 20 years. Prevention strategies, however, are limited. Pelvic inflammatory disease (PID) has been suggested to increase the risk of developing ovarian cancer, but the results of studies have been inconsistent. Therefore, we investigated whether PID increases the risk of developing ovarian cancer in a large, nationwide cohort. Methods From the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan, we obtained data for women aged 13–65 years for whom a diagnosis of PID, confirmed by multiple episodes, had been recorded between Jan 1, 2004, and Dec 31, 2005. We also obtained data for two controls per patient, matched for age and the year of first entry into the LHID2005. All patients were followed up from the date of entry in the LHID2005 until they developed ovarian cancer or to the end of 2006, whichever was earlier. We used Cox's regression models to assess the risk of developing ovarian cancer, with adjustment for age, comorbid disorders, and socioeconomic characteristics. Findings We identified 67 936 women with PID and 135 872 controls. Among these 90 had developed ovarian cancer during the 3-year follow-up period (42 patients with PID and 48 controls, incidence 2·78 and 1·44 per 10 000 person-years, respectively). The adjusted hazard ratio for ovarian cancer in patients with PID was 1·92 (95% CI 1·27–2·92) compared with controls, which rose to 2·46 (1·48–4·09) in women who had had at least five episodes of PID. The adjusted hazard ratio was slightly higher for women aged 35 years or younger with PID than in older women with PID (2·23, 1·02–4·79 vs 1·82, 1·10–3·04). Interpretation We found an association between PID and ovarian cancer. PID might, therefore, be a useful marker for ovarian cancer, and early treatment could help to improve prognosis. Whether pelvic inflammation itself accelerates the growth of ovarian cancers or affects cancer-cell differentiation in ways that adversely alter prognosis needs to be investigated. Funding None.
subject
0Adolescent
1Adult
2Age Factors
3Aged
4Cancer
5Case-Control Studies
6Comorbidity
7Databases as Topic
8Development and progression
9Family medicine
10Female
11Follow-Up Studies
12Hematology, Oncology and Palliative Medicine
13Humans
14Kaplan-Meier Estimate
15Medical colleges
16Middle Aged
17National Health Programs - statistics & numerical data
18Oncology, Experimental
19Ovarian cancer
20Ovarian Neoplasms - epidemiology
21Pelvic inflammatory disease
22Pelvic Inflammatory Disease - epidemiology
23Proportional Hazards Models
24Research
25Risk Assessment
26Risk Factors
27Socioeconomic Factors
28Taiwan - epidemiology
29Time Factors
30Women
31Young Adult
issn
01470-2045
11474-5488
fulltexttrue
rsrctypearticle
creationdate2011
recordtypearticle
recordideNqFkc2L1TAUxYsozjj6JyjBjbromJu0aTuCMgx-wYDgx8ZNSJMbzUza1KR98v57817HWbzNEGjC4Zwft_cUxVOgp0BBvP4GVUNLRqv6JcCrJkt1Ke4Vx1muyrpq2_v792o5Kh6ldEUpNEDrh8URg5bXouPHxc-vLl2TYEnYqOjUSLQaNUbiRvI3DJi_bv5NJvQbp7NovRoGNYe4JcYlVAnPiCJTmBavZhfGss-SIWlezPZx8cAqn_DJzX1S_Pjw_vvFp_Lyy8fPF-eXpa4aMZeoG2oNAKuYRdH3rKNUYG-pMo1AZmqNtusa3gkUjTa87Xtte82BWm7atuUnxYuVO8XwZ8E0y8Eljd6rEcOSZNsKQTnlkJ3PD5xXYYljHi6bGqiho3U2na6mX8qjzL8c5qh0PgYHp8OI1mX9nIm6YqJlLAfqNaBjSCmilVN0g4pbCVTuupL7ruSuCAkg911JkXPPbqZZ-gHNbep_Odnw5gCs3bxfc57I-Tvx79Y05t1vHEaZtMNcrnER9SxNcHcS3h4QtHej08pf4xbT7e5AJibpCtkxAPYEwf8BuN_K2Q
startdate2011
enddate2011
creator
0Lin, Hui-Wen, PhD
1Tu, Ying-Yueh, MD
2Lin, Shiyng Yu, MD
3Su, Wei-Ju, MA
4Lin, Wei Li, BA
5Lin, Wei Zer, BA
6Wu, Shen-Chi, MD
7Lai, Yuen-Liang, Dr
general
0Elsevier Ltd
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
90TZ
103V.
117RV
127TO
137X7
147XB
1588E
168AO
178C1
188C2
198FI
208FJ
218FK
22ABUWG
23BENPR
24FYUFA
25GHDGH
26H94
27K9.
28KB0
29M0S
30M1P
31NAPCQ
32PQEST
33PQQKQ
34PQUKI
35PRINS
367X8
sort
creationdate2011
titleRisk of ovarian cancer in women with pelvic inflammatory disease: a population-based study
authorLin, Hui-Wen, PhD ; Tu, Ying-Yueh, MD ; Lin, Shiyng Yu, MD ; Su, Wei-Ju, MA ; Lin, Wei Li, BA ; Lin, Wei Zer, BA ; Wu, Shen-Chi, MD ; Lai, Yuen-Liang, Dr
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c476t-ec70fd11242fe6bb29006ebf0ad76e2d5cef997396e67cd38bbcfbc310f3d8883
rsrctypearticles
prefilterarticles
languageeng
creationdate2011
topic
0Adolescent
1Adult
2Age Factors
3Aged
4Cancer
5Case-Control Studies
6Comorbidity
7Databases as Topic
8Development and progression
9Family medicine
10Female
11Follow-Up Studies
12Hematology, Oncology and Palliative Medicine
13Humans
14Kaplan-Meier Estimate
15Medical colleges
16Middle Aged
17National Health Programs - statistics & numerical data
18Oncology, Experimental
19Ovarian cancer
20Ovarian Neoplasms - epidemiology
21Pelvic inflammatory disease
22Pelvic Inflammatory Disease - epidemiology
23Proportional Hazards Models
24Research
25Risk Assessment
26Risk Factors
27Socioeconomic Factors
28Taiwan - epidemiology
29Time Factors
30Women
31Young Adult
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Lin, Hui-Wen, PhD
1Tu, Ying-Yueh, MD
2Lin, Shiyng Yu, MD
3Su, Wei-Ju, MA
4Lin, Wei Li, BA
5Lin, Wei Zer, BA
6Wu, Shen-Chi, MD
7Lai, Yuen-Liang, Dr
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8Pharma and Biotech Premium PRO
9ProQuest Central (Corporate)
10Nursing & Allied Health Database
11Oncogenes and Growth Factors Abstracts
12Health & Medical Collection
13ProQuest Central (purchase pre-March 2016)
14Medical Database (Alumni Edition)
15ProQuest Pharma Collection
16Public Health Database
17Lancet Titles
18Hospital Premium Collection
19Hospital Premium Collection (Alumni Edition)
20ProQuest Central (Alumni) (purchase pre-March 2016)
21ProQuest Central (Alumni Edition)
22ProQuest Central
23Health Research Premium Collection
24Health Research Premium Collection (Alumni)
25AIDS and Cancer Research Abstracts
26ProQuest Health & Medical Complete (Alumni)
27Nursing & Allied Health Database (Alumni Edition)
28Health & Medical Collection (Alumni Edition)
29Medical Database
30Nursing & Allied Health Premium
31ProQuest One Academic Eastern Edition
32ProQuest One Academic
33ProQuest One Academic UKI Edition
34ProQuest Central China
35MEDLINE - Academic
jtitleThe lancet oncology
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Lin, Hui-Wen, PhD
1Tu, Ying-Yueh, MD
2Lin, Shiyng Yu, MD
3Su, Wei-Ju, MA
4Lin, Wei Li, BA
5Lin, Wei Zer, BA
6Wu, Shen-Chi, MD
7Lai, Yuen-Liang, Dr
formatjournal
genrearticle
ristypeJOUR
atitleRisk of ovarian cancer in women with pelvic inflammatory disease: a population-based study
jtitleThe lancet oncology
addtitleLancet Oncol
date2011
risdate2011
volume12
issue9
spage900
epage904
pages900-904
issn1470-2045
eissn1474-5488
codenLANCAO
abstractSummary Background Ovarian cancer is commonly fatal and incidence has persistently risen in Taiwan over the past 20 years. Prevention strategies, however, are limited. Pelvic inflammatory disease (PID) has been suggested to increase the risk of developing ovarian cancer, but the results of studies have been inconsistent. Therefore, we investigated whether PID increases the risk of developing ovarian cancer in a large, nationwide cohort. Methods From the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan, we obtained data for women aged 13–65 years for whom a diagnosis of PID, confirmed by multiple episodes, had been recorded between Jan 1, 2004, and Dec 31, 2005. We also obtained data for two controls per patient, matched for age and the year of first entry into the LHID2005. All patients were followed up from the date of entry in the LHID2005 until they developed ovarian cancer or to the end of 2006, whichever was earlier. We used Cox's regression models to assess the risk of developing ovarian cancer, with adjustment for age, comorbid disorders, and socioeconomic characteristics. Findings We identified 67 936 women with PID and 135 872 controls. Among these 90 had developed ovarian cancer during the 3-year follow-up period (42 patients with PID and 48 controls, incidence 2·78 and 1·44 per 10 000 person-years, respectively). The adjusted hazard ratio for ovarian cancer in patients with PID was 1·92 (95% CI 1·27–2·92) compared with controls, which rose to 2·46 (1·48–4·09) in women who had had at least five episodes of PID. The adjusted hazard ratio was slightly higher for women aged 35 years or younger with PID than in older women with PID (2·23, 1·02–4·79 vs 1·82, 1·10–3·04). Interpretation We found an association between PID and ovarian cancer. PID might, therefore, be a useful marker for ovarian cancer, and early treatment could help to improve prognosis. Whether pelvic inflammation itself accelerates the growth of ovarian cancers or affects cancer-cell differentiation in ways that adversely alter prognosis needs to be investigated. Funding None.
copEngland
pubElsevier Ltd
pmid21835693
doi10.1016/S1470-2045(11)70165-6